95963-38-5

Upstream product

• 95963-36-3 4-Oxo-pentanoic acid (2R,3S,5R)-2-[(4-methoxy-phenyl)-diphenyl-methoxymethyl]-5-(5-methyl-2-oxo-4-[1,2,4]triazol-1-yl-2H-pyrimidin-1-yl)-tetrahydro-furan-3-yl ester 
• 95963-34-1 4-Oxo-pentanoic acid (2R,3S,5R)-2-[(4-methoxy-phenyl)-diphenyl-methoxymethyl]-5-(5-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-tetrahydro-furan-3-yl ester 
• 95963-35-2 4-Oxo-pentanoic acid (2R,3S,5R)-2-[(4-methoxy-phenyl)-diphenyl-methoxymethyl]-5-[5-methyl-2-oxo-4-(toluene-4-sulfonyloxy)-2H-pyrimidin-1-yl]-tetrahydro-furan-3-yl ester 
• 95963-37-4 4-Oxo-pentanoic acid (2R,3S,5R)-2-[(4-methoxy-phenyl)-diphenyl-methoxymethyl]-5-(5-methyl-2-oxo-4-tetrazol-1-yl-2H-pyrimidin-1-yl)-tetrahydro-furan-3-yl ester 

Downstream Products

• 95963-39-6 4-Oxo-pentanoic acid (2R,3S,5R)-5-(4-benzoylamino-5-methyl-2-oxo-2H-pyrimidin-1-yl)-2-[(4-methoxy-phenyl)-diphenyl-methoxymethyl]-tetrahydro-furan-3-yl ester 

Relevant academic research and scientific papers

CHEMISCHE SYNTHESE VON NONADESOXYRIBONUCLEOTIDEN MIT DEN ABGEWANDELTEN BASEN URACIL, 5-BROMURACIL UND 5-METHYLCYTOSIN NACH DEM TRIESTER-VERFAHREN

In order to investigate the interaction of Eco RII restriction and modification enzymes with synthetic DNA fragments three nonadeoxyribonucleotides containing the modified bases uracil, 5-bromouracil and 5-methylcytosine were synthesized according to the